Inventor · disambiguated record
Per Borgström
Also filed as: BORGSTROM PER · BORGSTROM PER HENRIK · BORGSTRÖM PER
14 granted patents·11 pending applications·49 citations·filing 2001–2024
89Inventor score
Files withPELLFICURE PHARMACEUTICALS INC8UNIV CALIFORNIA8HALOZYME INC5BORGSTRÖM PER1FROST GREGORY I1
Top patents by PatentIndex Score
25 records- 0196US7718428B2Myeloid colony stimulating factor and uses thereofHALOZYME INC·Filed 2006·Granted May 18, 2010·27 cites·3 claims
- 0287US9655868B2Treatment of prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2015·Granted May 23, 2017·6 cites·17 claims
- 0382US12279885B2System for health monitoring on prosthetic and fixation devicesUNIV CALIFORNIA·Filed 2024·Granted Apr 22, 2025·0 cites·18 claims
- 0480US7538097B2Inhibition of antigen presentation with poorly catabolized polymersHALOZYME INC·Filed 2001·Granted May 26, 2009·8 cites·9 claims
- 0579US11992335B2System for health monitoring on prosthetic and fixation devicesUNIV CALIFORNIA·Filed 2023·Granted May 28, 2024·0 cites·6 claims
- 0679US9132105B2Treatment of prostate carcinomaBORGSTRÖM PER·Filed 2011·Granted Sep 15, 2015·5 cites·18 claims
- 0773US7786096B2Inhibition of antigen presentation with poorly catabolized polymersHALOZYME INC·Filed 2009·Granted Aug 31, 2010·1 cites·12 claims
- 0866US11712201B2System for health monitoring on prosthetic and fixation devicesUNIV CALIFORNIA·Filed 2020·Granted Aug 1, 2023·0 cites·3 claims
- 0965US10959629B2Multisensor cardiac stroke volume monitoring system and analyticsUNIV CALIFORNIA·Filed 2018·Granted Mar 30, 2021·1 cites·29 claims
- 1064US10245240B2Treatment of prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2018·Granted Apr 2, 2019·0 cites·12 claims
- 1160US9877932B2Treatment of prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2017·Granted Jan 30, 2018·0 cites·25 claims
- 1259US10093620B2Compositions and methods for treatment of prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2015·Granted Oct 9, 2018·1 cites·15 claims
- 1359US2018116977A1Novel treatment of prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1458US2023329563A1Phonocardiogram (pcg) signal processing systems and methods for determining cardiac tissue and valvular blood flow parametersUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1557US2010331279A1Inhibition of Antigen Presentation with Poorly Catabolized PolymersHALOZYME INC·Filed 2010·Application pending·0 cites
- 1654US2003212021A1Myeloid colony stimulating factor and uses thereofFiled 2001·Application pending·0 cites
- 1754US2011212074A1Myeloid colony stimulating factor and uses thereofFROST GREGORY I·Filed 2011·Application pending·0 cites
- 1853US2011173709A1Ectopic, orthotopic model for revascularization and tumor assessmentSIDNEY KIMMEL CANCER CT·Filed 2008·Application pending·0 cites
- 1952US2010184845A1Myeloid Colony Stimulating Factor and Uses ThereofHALOZYME INC·Filed 2010·Application pending·0 cites
- 2052US2016015319A1System for health monitoring on prosthetic and fixation devicesUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 2151US2016022606A1Novel therapy for prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2250US2022304631A1Multisensor pulmonary artery and capillary pressure monitoring systemUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 2347US11234601B2Multisensor cardiac function monitoring and analytics systemsUNIV CALIFORNIA·Filed 2018·Granted Feb 1, 2022·0 cites·23 claims
- 2446US10577315B2Compositions and methods for treatment of prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2018·Granted Mar 3, 2020·0 cites·13 claims
- 2533US2018221306A1Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dionePELLFICURE PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Per Borgström files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →